4CPS-322 Adalimumab concentrations prior to the implementation of therapeutic drug monitoring in patients with inflammatory bowel disease

Added 392 days ago (28.04.2021)
Authors: Gracia Moya, A., Pau Parra, A., Sanchez Sancho, P., Cardona Pascual, I., Garcia Ortega, P., Torrecilla Vall-Llossera, B., Gorgas Torner, M., Miarons Font, M.
Read article